HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcelo Einicker-Lamas Selected Research

MicroRNAs (MicroRNA)

8/2014Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcelo Einicker-Lamas Research Topics

Disease

9Malnutrition (Nutritional Deficiencies)
10/2015 - 11/2004
3Hypertension (High Blood Pressure)
07/2017 - 10/2009
3Chronic Renal Insufficiency
01/2017 - 01/2009
2Proteinuria
01/2017 - 01/2011
2Fibrosis (Cirrhosis)
01/2017 - 12/2010
2Pneumonia (Pneumonitis)
01/2016 - 10/2010
2Infections
10/2014 - 12/2006
1Brain Neoplasms (Brain Tumor)
01/2021
1Neoplasms (Cancer)
01/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Ischemia
01/2018
1Heart Failure
07/2017
1Renovascular Hypertension (Goldblatt Syndrome)
01/2017
1Renal Artery Obstruction (Renal Artery Stenosis)
01/2017
1Edema (Dropsy)
01/2016
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2016
1Sepsis (Septicemia)
01/2016
1Chagas Disease (American Trypanosomiasis)
10/2014
1Hypoxia (Hypoxemia)
08/2014
1Reperfusion Injury
08/2014
1Cardiomegaly (Heart Hypertrophy)
01/2014
1Shock
06/2013
1Starvation
01/2011
1Ureteral Obstruction
12/2010
1Inflammation (Inflammations)
10/2010
1Atrophy
11/2004
1Poisoning
01/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
07/2017 - 10/2009
4Adenosine Triphosphate (ATP)IBA
01/2018 - 12/2009
3Adenosine Triphosphatases (ATPase)IBA
01/2018 - 01/2013
2Biological ProductsIBA
01/2021 - 01/2002
2Lysophosphatidic Acid ReceptorsIBA
01/2021 - 12/2010
2Surface-Active Agents (Surfactants)IBA
01/2016 - 11/2004
2Phosphotransferases (Kinase)IBA
01/2013 - 12/2006
1lysophosphatidic acidIBA
01/2021
1LysophospholipidsIBA
01/2021
1EndocannabinoidsIBA
01/2018
1EnzymesIBA
01/2018
1Antimycin AIBA
01/2018
1Blood Proteins (Serum Proteins)IBA
01/2017
1ReninIBA
01/2017
1LASSBIO596IBA
01/2016
1Protein Kinases (Protein Kinase)IBA
10/2015
1SphingosineIBA
10/2014
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
10/2014
1Sphingosine-1-Phosphate ReceptorsIBA
10/2014
1CytokinesIBA
10/2014
1Interleukin-17 (Interleukin 17)IBA
10/2014
1MicroRNAs (MicroRNA)IBA
08/2014
1Caspase 3 (Caspase-3)IBA
08/2014
1Losartan (Cozaar)FDA LinkGeneric
01/2014
1AcidsIBA
06/2013
1Phospholipids (Phosphatides)FDA LinkGeneric
04/2013
1CholesterolIBA
04/2013
1Tacrolimus Binding Proteins (FKBP)IBA
01/2013
1Angiotensin IIIBA
01/2011
1LipidsIBA
12/2010
1SphingolipidsIBA
12/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2010
1Particulate MatterIBA
10/2010
1SaltsIBA
10/2009
1CollagenIBA
01/2008
1Collagen Type I (Type I Collagen)IBA
11/2004
1MetalsIBA
01/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2021
1Surgical Instruments (Clip)
01/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2017
1Transplantation
01/2017
1Therapeutics
01/2016
1Intravenous Injections
12/2010
1Investigational Therapies (Experimental Therapy)
01/2009